|
Product |
Size |
Code |
DS |
|
EGF Anti-Human, made in Rabbit |
100 µg |
REL-102-PA10S |
|
|
EGF Anti-Human, made in Rabbit |
200 µg |
REL-102-PA10 |
|
|
anti-EGF Receptor (aa 1140-1160) (clone
EGFR-10F4)(Positive Control Included: HepG2,
untreated) |
100 µg |
NTL-0168-100 |
|
|
anti-EGF Receptor (aa 1140-1160) (clone
EGFR-10F4)(Positive Control Included: HepG2,
untreated) BIOTIN |
100 µg |
NTL-0168-100B |
|
|
anti-EGF Receptor (aa 960-980) (clone
EGFR-16F8)(Positive Control Included: HepG2,
untreated) |
100 µg |
NTL-0199-100 |
|
|
anti-EGF Receptor (aa 960-980) (clone
EGFR-16F8)(Positive Control Included: HepG2,
untreated) BIOTIN |
100 µg |
NTL-0199-100B |
|
|
anti-EGF Receptor (C-Terminus) (clone
EGFR-13G8)(Positive Control Included: HepG2,
untreated) |
100 µg |
NTL-0007-100 |
|
|
anti-EGF Receptor (C-Terminus) (clone
EGFR-13G8)(Positive Control Included: HepG2,
untreated) BIOTIN |
100 µg |
NTL-0007-100B |
|
|
anti-EGF Receptor (extracellular domain) (clone
EGFR-20E12)(Positive Control Included: A431,
untreated) |
100 µg |
NTL-0209-100 |
|
|
anti-EGF Receptor (extracellular domain) (clone
EGFR-20E12)(Positive Control Included: A431,
untreated) BIOTIN |
100 µg |
NTL-0209-100B |
|
|
anti-EGF Receptor (N-Terminus) (clone
EGFR-14C8)(Positive Control Included: HepG2,
untreated) |
100 µg |
NTL-0201-100 |
|
|
anti-EGF Receptor (N-Terminus) (clone
EGFR-14C8)(Positive Control Included: HepG2,
untreated) BIOTIN |
100 µg |
NTL-0201-100B |
|
|
anti-EGF Receptor (pSer 1047) (clone
EGFR-1H9)(Positive Control Included: HepG2,
pervanadate-treated) |
100 µg |
NTL-0107-100 |
|
|
anti-EGF Receptor (pSer 1047) (clone
EGFR-1H9)(Positive Control Included: HepG2,
pervanadate-treated) BIOTIN |
100 µg |
NTL-0107-100B |
|
|
anti-EGF Receptor (pThr 654) (clone
EGFR-3F2)(Positive Control Included: HepG2, PMA
+ vanadate) |
100 µg |
NTL-0138-100 |
|
|
anti-EGF Receptor (pThr 654) (clone
EGFR-3F2)(Positive Control Included: HepG2, PMA
+ vanadate) BIOTIN |
100 µg |
NTL-0138-100B |
|
|
anti-EGF Receptor (pThr 669) (clone
EGFR-5F10)(Positive Control Included: A431, PMA
+ pervanadate) |
100 µg |
NTL-0191-100 |
|
|
anti-EGF Receptor (pThr 669) (clone
EGFR-5F10)(Positive Control Included: A431, PMA
+ pervanadate) BIOTIN |
100 µg |
NTL-0191-100B |
|
|
anti-EGF Receptor (pTyr 1045) (clone
EGFR-11C2)(Positive Control Included: HepG2,
pervanadate-treated) |
100 µg |
NTL-0136-100 |
|
|
anti-EGF Receptor (pTyr 1045) (clone
EGFR-11C2)(Positive Control Included: HepG2,
pervanadate-treated) BIOTIN |
100 µg |
NTL-0136-100B |
|
|
anti-EGF Receptor (pTyr 1068) (clone
EGFR-15A2)(Positive Control Included: HepG2,
pervanadate-treated) |
100 µg |
NTL-0187-100 |
|
|
anti-EGF Receptor (pTyr 1068) (clone
EGFR-15A2)(Positive Control Included: HepG2,
pervanadate-treated) BIOTIN |
100 µg |
NTL-0187-100B |
|
|
anti-EGF Receptor (pTyr 1086) (clone
EGFR-8B8)(Positive Control Included: A431,
pervanadate-treated) |
100 µg |
NTL-0188-100 |
|
|
anti-EGF Receptor (pTyr 1086) (clone
EGFR-8B8)(Positive Control Included: A431,
pervanadate-treated) BIOTIN |
100 µg |
NTL-0188-100B |
|
|
anti-EGF Receptor (pTyr 1148) (clone
EGFR-10G12)(Positive Control Included: HepG2,
EGF-treated) |
100 µg |
NTL-0219-100 |
|
|
anti-EGF Receptor (pTyr 1148) (clone
EGFR-10G12)(Positive Control Included: HepG2,
EGF-treated) BIOTIN |
100 µg |
NTL-0219-100B |
|
|
anti-EGF Receptor (pTyr 1173) (clone
EGFR-9H2)(Positive Control Included: HepG2,
pervanadate-treated) |
100 µg |
NTL-0008-100 |
|
|
anti-EGF Receptor (pTyr 1173) (clone EGFR-9H2)
FITC |
100 µg |
NTL-0008-100F |
|
|
anti-EGF Receptor (pTyr 1173) (clone
EGFR-9H2)(Positive Control Included: HepG2,
pervanadate-treated) BIOTIN |
100 µg |
NTL-0008-100B |
|
|
anti-EGF Receptor (pTyr 845) (clone
EGFR-12A3)(Positive Control Included: HepG2,
EGF-treated) |
100 µg |
NTL-0116-100 |
|
|
anti-EGF Receptor (pTyr 845) (clone EGFR-12A3)
FITC |
100 µg |
NTL-0116-100F |
|
|
anti-EGF Receptor (pTyr 845) (clone
EGFR-12A3)(Positive Control Included: HepG2,
EGF-treated) BIOTIN |
100 µg |
NTL-0116-100B |
|
|
anti-EGF Receptor (Tyr 1173) (clone
EGFR-20G3)(Positive Control Included: HepG2,
untreated) |
100 µg |
NTL-0009-100 |
|
|
anti-EGF Receptor (Tyr 1173) (clone
EGFR-20G3)(Positive Control Included: HepG2,
untreated) BIOTIN |
100 µg |
NTL-0009-100B |
|
|
anti-EGFP, mAB (rec.) (G3) |
100 µg |
AG-27B-0007-C100 |
DS |
|
Endocan/ESM-1 Anti-Human, made in Rabbit |
100 µg |
REL-102-PA44S |
|
|
Endocan/ESM-1 Anti-Mouse, made in Rabbit |
100 µg |
REL-103-PA44S |
|
|
Endocan/ESM-1 Anti-Mouse, made in Rabbit |
200 µg |
REL-103-PA44 |
|
|
Endocan/ESM-1 Anti-Human, made in Rabbit |
200 µg |
REL-102-PA44 |
|
|
Endomucin Anti-Human, made in Rabbit |
100 µg |
REL-102-PA49S |
|
|
Endomucin Anti-Mouse, made in Rabbit |
100 µg |
REL-103-PA49S |
|
|
Endomucin Anti-Mouse, made in Rabbit |
50 µg |
REL-103-PA49AG |
|
|
Endomucin Anti-Human, made in Rabbit |
200 µg |
REL-102-PA49 |
|
|
Endomucin Anti-Mouse, made in Rabbit |
200 µg |
REL-103-PA49 |
|
|
Mouse Anti-Human Eotaxin-1 (CCL11) IgG |
100 ug |
V3-AB-12610 |
DS |
|
Ephrin-B2 Anti-human, made in Rabbit |
100 µg |
REL-102-PA136S |
|
|
Ephrin-B2 Anti-human, made in Rabbit |
50 µg |
REL-102-PA136AG |
|
|
Ephrin-B2 Anti-human, made in Rabbit |
200 µg |
REL-102-PA136 |
|
|
Rabbit Anti-Human Epidermal growth factor (EGF)
IgG, aff pure |
100 ul |
V3-EGF11-A |
DS |
|
Mouse monoclonal Anti-Human Epidermal growth
factor (EGF) IgG, Clone 1 |
100 ul |
V3-EGF12-M |
DS |
|
Mouse monoclonal Anti-Human Epidermal growth
factor (EGF) IgG, Clone 2 |
100 ul |
V3-EGF13-M |
DS |
|
anti-erbB2 (pTyr 1112) (clone
erbB2-19G5)(Positive Control Included: SKOV3,
EGF-treated) BIOTIN |
100 µg |
NTL-0216-100B |
|
|
Mouse Monoclonal Anti-human Erythropoietin (EPO)
IgG, aff pure |
100 ug |
V3-EPO11-M |
DS |
|
Mouse monoclonal anti-human Erythropoietin (EPO)
IgG-Biotinylated |
50 tests |
V3-EPO11-B |
DS |
|
Mouse monoclonal anti-human Erythropoietin (EPO)
IgG-FITC conjugate |
50 tests |
V3-EPO11-F |
DS |
|
ESAM Anti-Human, made in Rabbit |
100 µg |
REL-102-PA42S |
|
|
ESAM Anti-Human, made in Rabbit |
50 µg |
REL-102-PA42AG |
|
|
ESAM Anti-Human, made in Rabbit |
200 µg |
REL-102-PA42 |
|
|
ESL-1 Anti-Human, made in Rabbit |
100 µg |
REL-102-PA48S |
|
|
ESL-1 Anti-Human, made in Rabbit |
200 µg |
REL-102-PA48 |
|
|
anti-FABP3 (human), pAb |
100 µg |
AG-25A-0040-C100 |
DS |
|
FABP4 Anti-Human, made in Rabbit |
100 µg |
REL-102-PA134S |
|
|
FABP4 Anti-Human, made in Rabbit |
50 µg |
REL-102-PA134AG |
|
|
FABP4 Anti-Human, made in Rabbit |
200 µg |
REL-102-PA134 |
|
|
anti-FABP4 (human), pAb |
100 µg |
AG-25A-0041-C100 |
DS |
|
FABP5 Anti-Human, made in Rabbit |
100 µg |
REL-102-PA142S |
|
|
FABP5 Anti-Human, made in Rabbit |
50 µg |
REL-102-PA142AG |
|
|
FABP5 Anti-Human, made in Rabbit |
200 µg |
REL-102-PA142 |
|
|
Mouse Anti-Human FAS (CD95) Activating antibody
IgG |
100 ug |
V3-AB-20510 |
DS |
|
Mouse Monoclonal Anti-Human FAS (CD95) Blocking
antibody IgG |
100 ug |
V3-AB-20410 |
DS |
|
anti-Fas (human), mAb (APO-1-1) (preservative
free) |
100 µg |
AG-20B-0079PF-C100 |
DS |
|
anti-Fas (human), mAb (APO-1-1) (preservative
free) |
500 µg |
AG-20B-0079PF-C500 |
DS |
|
anti-Fas (human), mAb (APO-1-3) (preservative
free) |
50 µg |
AG-20B-0062PF-C050 |
DS |
|
anti-Fas (human), mAb (APO-1-3) (preservative
free) |
100 µg |
AG-20B-0062PF-C100 |
DS |
|
anti-Fas (human), mAb (APO-1-3) (preservative
free) |
500 µg |
AG-20B-0062PF-C500 |
DS |
|
Anti-Rat FAS Ligand Antiserum # 1 |
100 ul |
V3-FASL11-S |
DS |
|
Anti-Human FAS Ligand Antiserum # 2, |
100 ul |
V3-FASL12-S |
DS |
|
Anti-Rat FAS Ligand IgG # 1, aff pure |
100 ug |
V3-FASL11-A |
DS |
|
Anti-Human FAS Ligand IgG # 2, aff pure |
100 ug |
V3-FASL12-A |
DS |
|
Mouse-Anti-Rat FAS Ligand IgG #2, aff pure |
100 ug |
V3-FASL14-M |
DS |
|
Anti-Human FAS Ligand IgG, aff pure |
100 ug |
V3-FASL15-A |
DS |
|
Rat-Anti-mouse FAS Ligand IgG, aff pure |
100 ug |
V3-FASL16-M |
DS |
|
Rat-Anti-mouse FAS/TNFRSF6 (CD95) protein IgG,
aff pure |
100 ug |
V3-FAS21-M |
DS |
|
Mouse-Anti-human FAS/TNFRSF6 (CD95) protein IgG,
aff pure (FAS activating antibody) |
100 ug |
V3-FAS22-M |
DS |
|
Mouse-Anti-human FAS/TNFRSF6 (CD95) protein IgG,
aff pure (FAS Blocking antibody) |
100 ug |
V3-FAS23-M |
DS |
|
FGF-2 (basic) Anti-Human, made in Rabbit |
100 µg |
REL-102-PA08S |
|
|
FGF-2 (basic) Anti-Human, made in Rabbit |
200 µg |
REL-102-PA08 |
|
|
anti-FGF-19 (human), mAb (FG369-1) |
50 µg |
AG-20A-0066-C050 |
DS |
|
anti-FGF-19 (human), mAb (FG369-1) |
100 µg |
AG-20A-0066-C100 |
DS |
|
anti-FGF-19 (human), mAb (FG98-6) |
50 µg |
AG-20A-0065-C050 |
DS |
|
anti-FGF-19 (human), mAb (FG98-6) |
100 µg |
AG-20A-0065-C100 |
DS |
|
anti-FGF-21 (mouse), pAb |
100 µg |
AG-25A-0076-C100 |
DS |
|
anti-FGF-21, mAb (FG224-7) |
100 µg |
AG-20A-0051-C100 |
DS |
|
anti-FGF-21, pAb |
100 µg |
AG-25A-0074-C100 |
DS |
|
anti-FGF-23 (human), mAb (FG322-3) |
50 µg |
AG-20A-0073-C050 |
DS |
|
anti-FGF-23 (human), mAb (FG322-3) |
100 µg |
AG-20A-0073-C100 |
DS |
|
FGFR-3 neutralizing antibody Anti-Human, made in
E. coli |
100 µg |
REL-500-002 |
|
|
Rabbit Anti-human Fibrinogen-like protein 2
(FGL2) IgG, aff pure |
100 ul |
V3-FGL21-A |
DS |
|
anti-FLIP (human), mAb (NF6) |
50 µg |
AG-20B-0056-C050 |
DS |
|
anti-FLIP (human), mAb (NF6) |
100 µg |
AG-20B-0056-C100 |
DS |
|
anti-FLIP, mAb (Dave-2) |
100 µg |
AG-20B-0005-C100 |
DS |
|
Biotinylated-Mouse Monoclonal Anti-Human
FLK-1/VEGFR-2 IgG # 3 |
100 ug |
V3-FLK13-MB |
DS |
|
Rabbit Anti-Mouse FLK-1/VEGFR-2 IgG #1, aff pure |
100 ug |
V3-FLK11-A |
DS |
|
Rabbit Anti-Mouse FLT-1/VEGFR-1 (279-299aa) IgG,
aff pure |
100 ul |
V3-FLT15-A |
DS |
|
Rabbit Anti-human FLT-1/VEGFR-1 IgG #1, aff pure |
100 ul |
V3-FLT11-A |
DS |
|
Mouse Monoclonal Anti-human FLT-1/VEGFR-1 IgG,
aff pure |
100 ug |
V3-FLT12-M |
DS |
|
Mouse Monoclonal Anti-human FLT-1/VEGFR-1 IgG,
aff pure |
100 ug |
V3-FLT14-M |
DS |
|
Rabbit Anti-Mouse FLT-4/VEGFR-3 IgG #1, aff pure |
100 ug |
V3-FLT41-A |
DS |
|
Rabbit Anti-Human FLT-4/VEGFR-3 IgG #2, aff pure |
100 ug |
V3-FLT42-A |
DS |
|
anti-FOXP3 (mouse), pAb |
100 µg |
AG-25A-0035-C100 |
DS |
|
anti-FOXP3 (mouse), pAb |
100 µg |
AG-25A-0020-C100 |
DS |
|
anti-FTO (human), mAb (AG103) |
50 µg |
AG-20A-0092-C050 |
DS |
|
anti-FTO (human), mAb (AG103) |
100 µg |
AG-20A-0092-C100 |
DS |
|
anti-FTO, mAb (FT86-4) |
50 µg |
AG-20A-0064-C050 |
DS |
|
anti-FTO, mAb (FT86-4) |
100 µg |
AG-20A-0064-C100 |
DS |
|
anti-FTO (human), pAb |
100 µg |
AG-25A-0084-C100 |
DS |
|
anti-FTO (mouse), mAb (FT62-6) |
50 µg |
AG-20A-0083-C050 |
DS |
|
anti-FTO (mouse), mAb (FT62-6) |
100 µg |
AG-20A-0083-C100 |
DS |
|
anti-FTO (mouse), pAb |
100 µg |
AG-25A-0089-C100 |
DS |
|
Anti-Mouse gAcrp30 (globular adipocyte
complement-related protein of 30 kDa) antiserum
# 3 |
100 ul |
V3-ACRP303-S |
DS |
|
Anti-Mouse gAcrp30 (globular adipocyte
complement-related protein of 30 kDa) IgG # 3,
aff pure |
100 ug |
V3-ACRP303-A |
DS |
|
Anti-Human gAcrp30 (globular adipocyte
complement-related protein of 30 kDa) protein
antiserum # 4 |
100 ul |
V3-ACRP304-S |
DS |
|
Galectin-1 Anti-Human, made in Rabbit |
100 µg |
REL-102-PA131S |
|
|
Galectin-1 Anti-Human, made in Rabbit |
50 µg |
REL-102-PA131AG |
|
|
Galectin-1 Anti-Human, made in Rabbit |
200 µg |
REL-102-PA131 |
|
|
anti-Gasdermin D (mouse), pAb (IN110) |
100 µg |
AG-25B-0036-C100 |
DS |
|
anti-Giantin, mAb (rec.) (TA10) |
100 µg |
AG-27B-0003-C100 |
DS |
|
anti-Giantin, mAb (rec.) (TA10) (ATTO 488) |
100 µg |
AG-27B-0003TD-C100 |
DS |
|
Anti-GITR Antibody |
50 µg |
BPS-79053-1 |
DS |
|
Anti-GITR Antibody |
100 µg |
BPS-79053-2 |
DS |
|
Anti-GITR Antibody, PE-labeled |
50 µg |
BPS-71295-1 |
DS |
|
Anti-GITR Antibody, PE-labeled |
100 µg |
BPS-71295-2 |
DS |
|
Monoclonal Anti-Human Glial Derived Neurotrophic
Factor (GDNF) protein IgG, aff pure |
100 ug |
V3-GDNF11-M |
DS |
|
Anti-human Glucagon like peptide 1 (GLP-1/GLP1)
IgG #1, aff pure |
100 ug |
V3-GLP15-A |
DS |
|
Anti-mouse Glucagon like peptide 1 receptor
(GLP1R) IgG #1, aff pure |
100 ug |
V3-GLP1R11-A |
DS |
|
Anti-human Glucagon like peptide 2 (GLP2/GLP-2)
IgG #1, aff pure |
100 ug |
V3-GLP25-A |
DS |
|
Anti-human Glucagon like peptide 2
receptor(GLP2R) IgG #1, aff pure |
100 ug |
V3-GLP2R11-A |
DS |
|
Anti-human Glucagon like peptide 2
receptor(GLP2R) IgG #2, aff pure |
100 ug |
V3-GLP2R12-A |
DS |
|
Anti-human Glucagon like peptide 2
receptor(GLP2R) IgG #3, aff pure |
100 ug |
V3-GLP2R13-A |
DS |
|
GM-CSF Anti-Mouse, made in Rabbit |
100 µg |
REL-103-PA06S |
|
|
GM-CSF Anti-Mouse, made in Rabbit |
50 µg |
REL-103-PA06AG |
|
|
GM-CSF Anti-Mouse, made in Rabbit |
200 µg |
REL-103-PA06 |
|
|
anti-Granulin C (human), pAb |
100 µg |
AG-25A-0090-C100 |
DS |
|
Anti-Human GCSF protein IgG, aff pure |
100 ug |
V3-GCSF12-A |
DS |
|
Anti-Mouse GCSF protein IgG, aff pure |
100 ug |
V3-GCSF11-A |
DS |
|
Monoclonal Anti-Human GCSF protein IgG, aff pure |
100 ug |
V3-GCSF13-M |
DS |
|
Monoclonal Anti-Human GCSF receptor protein IgG,
aff pure |
100 ug |
V3-GCSFR14-M |
DS |
|
Gremlin-1 Anti-Mouse, made in Rabbit |
100 µg |
REL-103-PA46S |
|
|
Gremlin-1 Anti-Human, made in Rabbit |
100 µg |
REL-102-PA46S |
|
|
Gremlin-1 Anti-Mouse, made in Rabbit |
200 µg |
REL-103-PA46 |
|
|
Gremlin-1 Anti-Human, made in Rabbit |
200 µg |
REL-102-PA46 |
|
|
HGF Anti-Human, made in Rabbit |
100 µg |
REL-102-PA62S |
|
|
HGF Anti-Human, made in Rabbit |
50 µg |
REL-102-PA62AG |
|
|
HGF Anti-Human, made in Rabbit |
200 µg |
REL-102-PA62 |
|
|
anti-HMGB1, mAb (rec.) (Giby-1-4) |
100 µg |
AG-27B-0002-C100 |
DS |
|
anti-HMGB1, mAb (rec.) (Giby-1-4) (Biotin) |
100 µg |
AG-27B-0002B-C100 |
DS |
|
anti-hsp27 (pSer 82) (clone hsp27-5B9)(Positive
Control Included: HepG2, EGF-treated) BIOTIN |
100 µg |
NTL-0117-100B |
|
|
Humanized Monoclonal Anti-Human VEGF protein
(Avastin/bevacizumab biosimilar) protein IgG1
(neutralizing) |
50 ug |
V3-VEGF19-M |
DS |
|
ICOS/CD278 (C-Term) Rabbit Monoclonal Antibody |
100 µL |
CAY-32338-100 |
DS |
